Search Results - Benjamin Lockshin
- Showing 1 - 4 results of 4
-
1
Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin Accord... by Michael J. Cork, Benjamin Lockshin, Andreas Pinter, Zhen Chen, Brad Shumel, Randy Prescilla
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
A case report of uveitis secondary to dupilumab treatment for atopic dermatitis by Marissa Ayasse, BS, Benjamin Lockshin, MD, Brian K. Do, MD, Rachel Kaiser, MD, MPH, Jonathan I. Silverberg, MD, PhD, MPH
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel by Joshua Burshtein, Milaan Shah, Danny Zakria, Benjamin Lockshin, Jeff Crowley, Joseph F. Merola, Ken Gordon, Mona Shahriari, Neil J. Korman, Raj Chovatiya, Robert Kalb, Mark Lebwohl
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis by Andrew F. Alexis, Melinda Gooderham, Shawn G. Kwatra, Ahmad Amin, Susan Taylor, Ramon Espaillat, Trisha Rettig, Tianshuang Wu, Linyu Shi, Mark I. Kaldas, Deanne M. Dilley, Ranjeeta Sinvhal, Chudy Nduaka, Benjamin Lockshin
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book